The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, that are also associated with male hypogonadism (MH). Therefore, obesity has been classically identified as the most evident link...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Andrea Graziani, Giuseppe Grande, Alberto Ferlin
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	Frontiers Media S.A. 2023-10-01
Saila:	Frontiers in Reproductive Health
Gaiak:	OSAS hypogonadism testosterone testosterone replacement therapy obesity
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/frph.2023.1219239/full

Antzeko izenburuak

Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
nork: Julius Fink, et al.
Argitaratua: (2024-02-01)

Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
nork: N. I. Volkova, et al.
Argitaratua: (2022-09-01)

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism
nork: Paolo Facondo, et al.
Argitaratua: (2022-12-01)

ASSESSING CARDIOVASCULAR SAFETY OF TESTOSTERONE REPLACEMENT THERAPY FOR MALE HYPOGONADISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
nork: Manarul Iman Alfafa Rachman, et al.
Argitaratua: (2024-09-01)

Impact of testosterone levels and testosterone replacement ther-apy on men’s health
nork: Zuzanna Karbowska, et al.
Argitaratua: (2023-12-01)

Acquired Male Hypogonadism in the Post-Genomic Era—A Narrative Review
nork: Giuseppe Grande, et al.
Argitaratua: (2023-09-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Argitaratua: (2012-12-01)

Plasma metabolomics in male primary and functional hypogonadism
nork: Giuseppe Grande, et al.
Argitaratua: (2023-05-01)

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
nork: Giuseppe Lisco, et al.
Argitaratua: (2020-10-01)

LATE ONSET HYPOGONADISM: TO TREAT, NOT TO TREAT AND WHO MUST TREAT?
nork: Z. R. Gusova, et al.
Argitaratua: (2016-03-01)

Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis
nork: Rossella Cannarella, et al.
Argitaratua: (2024-01-01)

Sleep disorders and testosterone deficiency in men
nork: I. A. Khripun, et al.
Argitaratua: (2025-01-01)

Evaluation of sexual functional status and consistency of scales in patients with hypogonadotropic hypogonadism before and after testosterone replacement therapy: a single-center experience
nork: Umit Aydogan, et al.
Argitaratua: (2023-01-01)

Application of Transdermal Testosterone in Treatment of Male Hypogonadism
nork: Mahgol Tajbakhsh, et al.
Argitaratua: (2018-10-01)

The association of hypogonadism with depression and its treatments
nork: Rita Indirli, et al.
Argitaratua: (2023-08-01)

Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men
nork: Geoffrey Hackett, et al.
Argitaratua: (2024-10-01)

Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
nork: Ivan I. Dedov, et al.
Argitaratua: (2017-12-01)

Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge
nork: Kristina Groti Antonič, et al.
Argitaratua: (2024-12-01)

The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
nork: Michael Zitzmann, et al.
Argitaratua: (2022-12-01)

Testosterone replacement therapy in adolescents and young men
nork: Alexandra Aponte Varnum, et al.
Argitaratua: (2024-10-01)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
nork: Maurício de Almeida Ferreira, et al.
Argitaratua: (2022-02-01)

A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation
nork: Andrew Morton, et al.
Argitaratua: (2021-01-01)

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
nork: Campbell K, et al.
Argitaratua: (2023-03-01)

Syndrome of hypogonadism in males
Argitaratua: (2014-06-01)

Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy
nork: Robert M. Coward, et al.
Argitaratua: (2010-12-01)

Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report
nork: Belinda F. Morrison, et al.
Argitaratua: (2015-11-01)

Osteoporosis and bone metabolism in patients with Klinefelter syndrome
nork: Giuseppe Grande, et al.
Argitaratua: (2023-07-01)

Testosterone and aging male, a perspective from a developing country
nork: Bac Nguyen Hoai, et al.
Argitaratua: (2023-12-01)

Testosterone treatment in the aging male: myth or reality?
nork: Nicole Nigro, et al.
Argitaratua: (2012-03-01)

Does Testosterone Salvage PDE5i Non-Responders? A Scoping Review
nork: Mike Pignanelli, et al.
Argitaratua: (2023-02-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
nork: Galina Afanas'evna Melnichenko, et al.
Argitaratua: (2017-06-01)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
nork: Kevin M. Pantalone, et al.
Argitaratua: (2019-03-01)

Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
nork: María Molina-Vega, et al.
Argitaratua: (2018-01-01)

The role of anti-aging approaches in managing hypogonadism in sedentary older males
nork: Khaled A. Abdel-Sater
Argitaratua: (2024-11-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Argitaratua: (2013-03-01)

High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study
nork: Amar Osmancevic, et al.
Argitaratua: (2022-06-01)

Association of hypogonadism with the severity of chronic obstructive pulmonary disease
nork: MA. Zohal, et al.
Argitaratua: (2015-12-01)

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus
nork: Galina A. Mel'nichenko, et al.
Argitaratua: (2019-12-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
nork: Galina A. Melnichenko, et al.
Argitaratua: (2019-06-01)

Clomiphene citrate treatment for late onset hypogonadism: rise and fall
nork: Marcelo Marconi, et al.